Internationally renowned uterine cancer researcher and geneticist Paul Goodfellow, MD, PhD, will lead a new team of three researchers devoted to gynecologic oncology research at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute.
Dr. Goodfellow comes to Ohio State from Washington University School of Medicine, where he was a professor of surgery, of genetics and of obstetrics and gynecology.
“As a geneticist, I’m interested in the genetics of tumor cells, and how gene changes influence how aggressively cancer cells will spread,” said Dr. Goodfellow, who has a doctorate of biology/pediatrics from Queen’s University, Kingston, Canada.
Throughout his career, Dr. Goodfellow’s research has made important contributions to improving women’s health care. He also has embraced his role in mentoring gynecologic oncologists in basic science and in translational research, helping to develop the next generation of physician scientists.
Dr. Goodfellow has a joint appointment within the Division of Gynecologic Oncology of Ohio State’s Comprehensive Cancer Center and within the Department of Obstetrics and Gynecology at Ohio State’s Wexner Medical Center.
While at the Siteman Cancer Center, Washington University School of Medicine, Dr. Goodfellow developed a prominent endometrial research group that focused on elucidating both the causes and consequences of defective DNA mismatch repair in endometrial cancer. The group’s translational research findings have significantly advanced knowledge about the most common gynecologic cancer.■
